Lensar (LNSR) Gains from Investment Securities (2023 - 2026)
Lensar (LNSR) posted quarterly Gains from Investment Securities of -$23.9 million for Q1 2026, down 210.29% year-over-year from $21.7 million in Q1 2025, and down 623.5% quarter-over-quarter from -$3.3 million in Q4 2025.
Lensar (LNSR) Gains from Investment Securities (2023 - 2026) Analysis & Trends
Lensar (LNSR) has reported Gains from Investment Securities for 4 consecutive years, with -$23.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 210.29% year-over-year to -$23.9 million; the TTM figure through Mar 2026 stood at -$35.3 million (down 181.0% YoY), while the FY2025 annual figure was $10.3 million, down 51.69% from the prior year.
- Gains from Investment Securities eased to -$23.9 million in Q1 2026 per LNSR's latest filing, from -$3.3 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $21.7 million in Q1 2025 and bottomed at -$23.9 million in Q1 2026.
- Historically, Gains from Investment Securities has averaged $886750.0 across 4 years, with a median of -$42500.0 in 2024.
- On a YoY basis, Gains from Investment Securities climbed as much as 4486.67% in 2025 and fell as far as 1010.73% in 2025.
- Lensar's Gains from Investment Securities stood at $1.2 million in 2023, then jumped by 1365.86% to $17.6 million in 2024, then slumped by 118.85% to -$3.3 million in 2025, then slumped by 623.5% to -$23.9 million in 2026.
- Business Quant data shows LNSR's Gains from Investment Securities at -$23.9 million in Q1 2026, -$3.3 million in Q4 2025, and -$3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Lensar | 103.79 Mn | 90.22 Mn | 9.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.23 Mn |
| Jun 30, 2026 | -1.23 Mn |
| Mar 31, 2026 | -23.95 Mn |
| Mar 31, 2026 | -23.95 Mn |
| Dec 31, 2025 | -3.31 Mn |
| Dec 31, 2025 | -3.31 Mn |
| Sep 30, 2025 | -3.73 Mn |
| Sep 30, 2025 | -3.73 Mn |
| Jun 30, 2025 | -4.33 Mn |
| Jun 30, 2025 | -4.33 Mn |
| Mar 31, 2025 | 21.71 Mn |
| Mar 31, 2025 | 21.71 Mn |
| Dec 31, 2024 | 17.56 Mn |
| Dec 31, 2024 | 17.56 Mn |
| Sep 30, 2024 | 410,000.00 |
| Sep 30, 2024 | 410,000.00 |
| Jun 30, 2024 | 3.92 Mn |
| Jun 30, 2024 | 3.92 Mn |
| Mar 31, 2024 | -495,000.00 |
| Mar 31, 2024 | -495,000.00 |